Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Anti-dilutive Securities (Details)

v3.22.2
Net Loss Per Share - Anti-dilutive Securities (Details) - $ / shares
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Jan. 31, 2021
Anti-dilutive securities        
Weighted average number of shares issuable (in shares) 139,747      
Exercise price per share (in dollars per share)   $ 0.012   $ 0.012
Pre-funded warrants exercised (in shares)     25,740  
Nantahala        
Anti-dilutive securities        
Warrants outstanding (in shares) 114,007      
Stock options        
Anti-dilutive securities        
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 1,379,570 1,053,785    
Warrants on common stock        
Anti-dilutive securities        
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 366,990 367,186    
Restricted Stock Units        
Anti-dilutive securities        
Anti-dilutive securities excluded from the computation of diluted weighted shares outstanding (in shares) 0 6,493